The best indicator for Monster Beverage (MNST)
We backtested 20 indicators across daily, weekly and hourly charts on real Monster Beverage (MNST) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Monster Beverage (MNST) over ~40.5 years — trailing buy-and-hold by 4.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 50/200 Cross ✓ | Daily | 14.6% | 0.53 | -84.3% | 42.9% | 28 | -4.9% |
| 2 | EMA 20/50 Cross ✓ | Weekly | 12.7% | 0.49 | -83.5% | 45.0% | 20 | -6.7% |
| 3 | ADX / DMI ✓ | Weekly | 13.1% | 0.48 | -74.2% | 50.9% | 55 | -6.3% |
| 4 | EMA 50/200 Cross ✓ | Daily | 10.9% | 0.45 | -87.2% | 29.0% | 31 | -8.6% |
| 5 | EMA 20/50 Cross ✓ | Daily | 10.9% | 0.45 | -93.6% | 45.1% | 82 | -8.5% |
| 6 | Bollinger Mean-Reversion ✓ | Daily | 9.6% | 0.42 | -86.3% | 59.1% | 164 | -9.9% |
| 7 | Stochastic ✓ | Daily | 9.2% | 0.42 | -87.5% | 63.3% | 158 | -10.3% |
| 8 | Donchian Midline ✓ | Weekly | 9.9% | 0.42 | -84.8% | 42.2% | 102 | -9.5% |
| 9 | RSI Trend (>50) ✓ | Weekly | 9.5% | 0.41 | -95.4% | 39.4% | 99 | -9.9% |
| 10 | Donchian Breakout | Weekly | 8.8% | 0.4 | -69.8% | 43.3% | 30 | -10.6% |
| 11 | Williams %R ✓ | Daily | 6.6% | 0.39 | -90.9% | 62.5% | 216 | -12.8% |
| 12 | Rate of Change ✓ | Weekly | 8.9% | 0.39 | -95.6% | 41.3% | 126 | -10.5% |
| 13 | Holy Grail Confluence ✓ | Daily | 7.8% | 0.36 | -74.1% | 67.9% | 56 | -11.7% |
| 14 | MACD ✓ | Weekly | 7.2% | 0.35 | -95.5% | 49.4% | 85 | -12.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Monster Beverage (MNST), SMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.